Ir para o conteúdo principal

United States Últimas notícias

Todas as matérias desta categoria, das mais recentes às mais antigas.

Grafa
Technology

GlobalFoundries to acquire Synopsys processor unit in "physical AI" expansion

Synopsys (NASDAQ:SNPS) has reached a definitive agreement to sell its Processor IP Solutions business to GlobalFoundries (NASDAQ:GFS), a strategic divestiture that signals a narrowing of focus for the EDA giant toward high-growth interface and foundational silicon IP.

Leia mais: GlobalFoundries to acquire Synopsys processor unit in "physical AI" expansion
Grafa
Health

Dr. Reddy’s launches first generic "extra strength" allergy eye drop in U.S.

Dr. Reddy’s Laboratories (NYSE:RDY) announced Wednesday the first-to-market launch of its over-the-counter (OTC) Olopatadine Hydrochloride Ophthalmic Solution, 0.7%, providing a lower-cost generic equivalent to Alcon’s Extra Strength Pataday® Once-Daily Relief.

Leia mais: Dr. Reddy’s launches first generic "extra strength" allergy eye drop in U.S.
Grafa

Citigroup profit surpasses estimates as dealmaking rebound offsets Russia exit loss

Citigroup (NYSE:C) reported fourth-quarter adjusted earnings that comfortably beat Wall Street expectations, as a resurgence in investment banking and the steady performance of its "crown jewel" services unit helped the bank weather a massive charge related to its exit from Russia.

Leia mais: Citigroup profit surpasses estimates as dealmaking rebound offsets Russia exit loss
Grafa
Technology

Diginex closes €55 million acquisition of Plan A to create ESG technology powerhouse

Diginex (NASDAQ:DGNX) finalized its acquisition of PlanA.earth GmbH on Wednesday, a transformative move that consolidates two of Europe’s leading sustainability platforms into a single, integrated "RegTech" giant.

Leia mais: Diginex closes €55 million acquisition of Plan A to create ESG technology powerhouse
Grafa
Health

Emergent BioSolutions wins FDA nod for discreet NARCAN carrying case to boost daily readiness

Emergent BioSolutions (NYSE:EBS) received FDA approval Wednesday for a redesigned, compact carrying case for its over-the-counter (OTC) NARCAN® Nasal Spray, a move aimed at overcoming the "stigma of carrying" that has long hampered community-level overdose responses.

Leia mais: Emergent BioSolutions wins FDA nod for discreet NARCAN carrying case to boost daily readiness
Grafa
Technology

Rail Vision acquires majority stake in Quantum Transportation to fuel AI-rail synergies

Rail Vision (NASDAQ:RVSN) announced Wednesday it has finalized the acquisition of a 51% ownership interest in Quantum Transportation, a strategic move that integrates cutting-edge quantum computing into the company’s suite of railway safety and autonomous driving technologies.

Leia mais: Rail Vision acquires majority stake in Quantum Transportation to fuel AI-rail synergies
Grafa

United Community Banks surges on record 2025 revenue and margin expansion

United Community Banks (NYSE:UCB) capped a historic 2025 on Wednesday, reporting record full-year revenue of $1.063 billion as the Greenville-based regional lender successfully navigated a volatile interest rate environment to deliver double-digit earnings growth.

Leia mais: United Community Banks surges on record 2025 revenue and margin expansion
Grafa
Health

NRx Pharmaceuticals submits landmark 70,000-patient data to FDA for suicide-prevention breakthrough

NRx Pharmaceuticals (NASDAQ:NRXP) achieved a pivotal regulatory milestone Wednesday, announcing the submission of a massive real-world dataset to the U.S. Food and Drug Administration (FDA) to support the accelerated approval of NRX-100, its proprietary preservative-free ketamine.

Leia mais: NRx Pharmaceuticals submits landmark 70,000-patient data to FDA for suicide-prevention breakthrough